| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/19/2013 | WO2013135103A1 Polypeptide carrying melittin, nanoparticle carrying melittin and use thereof |
| 09/19/2013 | WO2013113030A3 Fads regulation |
| 09/19/2013 | WO2013112856A3 Multifunctional nanomaterials for the treatment of cancer |
| 09/19/2013 | WO2013109675A3 Compositions and methods for treating cancer and inflammation-related diseases and conditions |
| 09/19/2013 | WO2013102878A3 Fat1 gene in cancer and inflammation |
| 09/19/2013 | WO2013080217A4 Crystalline forms of carbazitaxel and process for preparation thereof |
| 09/19/2013 | WO2012177925A8 Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene |
| 09/19/2013 | WO2012142687A8 Antitumour testosterone-(radioactive iodine) compound |
| 09/19/2013 | WO2012135970A8 Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants thereof and other members of the erbb/her family |
| 09/19/2013 | WO2012117257A8 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer |
| 09/19/2013 | US20130245226 Antibodies To Non-Functional P2X7 Receptor |
| 09/19/2013 | US20130245128 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/19/2013 | US20130245097 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 09/19/2013 | US20130245090 Identification of novel genes coding for small temporal rnas |
| 09/19/2013 | US20130245043 Substituted imidazopyrimidin-5(6h)-ones as allosteric modulators of mglur5 receptors |
| 09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
| 09/19/2013 | US20130244951 Treatment of solid tumors with rapamycin derivatives |
| 09/19/2013 | US20130244927 Polynucleotides encoding signal peptide-containing molecules |
| 09/19/2013 | US20130243813 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 09/19/2013 | US20130243811 Immunostimulatory oligonucleotides and uses thereof |
| 09/19/2013 | US20130243796 Genetic products differentially expressed in tumors and use thereof |
| 09/19/2013 | US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 09/19/2013 | US20130243755 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2013 | EP2639243A1 Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same |
| 09/18/2013 | EP2639242A2 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 09/18/2013 | EP2638916A1 Novel binding molecules with antitumoral activity |
| 09/18/2013 | EP2638913A1 Method for producing bioactive agent, bioactive agent produced thereby, cosmetic, freshness-maintaining agent, growth promotion agent, soil conditioning agent, and pharmaceutical stock solution |
| 09/18/2013 | EP2638912A1 Compositions containing antisense oligonucleotide to micro rna |
| 09/18/2013 | EP2638910A2 Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseases |
| 09/18/2013 | EP2638907A2 Combinations of an anti-HER2 antibody-drug conjugate and lapatinib |
| 09/18/2013 | EP2638896A1 Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood |
| 09/18/2013 | EP2638073A2 Protein complexes for antigen binding and methods of use |
| 09/18/2013 | EP2638061A1 Soluble pd-1 variants, fusion constructs, and uses thereof |
| 09/18/2013 | EP2638047A1 Substituted 4-beta-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof |
| 09/18/2013 | EP2638046A2 Spiro-oxindole mdm2 antagonists |
| 09/18/2013 | EP2638041A1 Substituted azaindazole compounds |
| 09/18/2013 | EP2638033A1 Compounds useful for inhibiting chk1 |
| 09/18/2013 | EP2638030A1 Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof |
| 09/18/2013 | EP2638026A2 Chromene derivatives and their analoga as wnt pathway antagonists |
| 09/18/2013 | EP2638025A2 Chromene derivatives and their analoga as wnt pathway antagonists |
| 09/18/2013 | EP2638021A2 Metalloenzyme inhibitor compounds |
| 09/18/2013 | EP2638009A2 Fluorinated hdac inhibitors and uses thereof |
| 09/18/2013 | EP2637700A2 Compositions and methods for the prevention and treatment of cancer |
| 09/18/2013 | EP2637693A2 System and method for generating micro-seismic events and characterizing properties of a medium with non-linear acoustic interactions |
| 09/18/2013 | EP2637681A2 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same |
| 09/18/2013 | EP2637680A2 Cancer therapies and diagnostics |
| 09/18/2013 | EP2637671A2 Cardiac glycoside analogs in combination with emodin for cancer therapy |
| 09/18/2013 | EP2637669A2 Heterocyclic compounds and uses thereof |
| 09/18/2013 | EP2637666A1 Combination of bevacizumab and 2,2-dimethyl-n-((s)-6-oxo-6,7-dihydro - 5h-dibenzo[b,d]azepin-7-yl)-n'-(2,2,3,3,3-pentafluoro-propyl)-malonamide for the treatment of proliferative disorders |
| 09/18/2013 | EP2637665A1 Dexamethasone combination therapy |
| 09/18/2013 | EP2637663A1 Combination therapy with an antitumor alkaloid |
| 09/18/2013 | EP2637661A1 Use of 2-carboxamide cycloamino urea derivatives in the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 09/18/2013 | EP2637660A1 Fatty acid synthase inhibitors |
| 09/18/2013 | EP2637502A1 Mutant-selective egfr inhibitors and uses thereof |
| 09/18/2013 | CN1895262B Emulsion for injecting epirubicin and its production |
| 09/18/2013 | CN1697655B Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 09/18/2013 | CN103314109A SiRNA for inhibition of Hif1a expression and anticancer composition containing same |
| 09/18/2013 | CN103314107A Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence |
| 09/18/2013 | CN103314102A Galectin 9-secreting cell, production method for same, and application for same |
| 09/18/2013 | CN103313992A Hdac inhibiting derivatives of camptothecin |
| 09/18/2013 | CN103313989A Tricyclic PI3K inhibitor compounds and methods of use |
| 09/18/2013 | CN103313970A Novel bicyclic compound or salt thereof |
| 09/18/2013 | CN103313968A Nampt and rock inhibitors |
| 09/18/2013 | CN103313730A Compositions of a peptide-based system for cell-specific targeting |
| 09/18/2013 | CN103313719A PEG or PEG block copolymers for treating colorectal cancer |
| 09/18/2013 | CN103313714A Dexamethasone combination therapy |
| 09/18/2013 | CN103313701A Pharmaceutical compositions of pyridinium and quinolinium derivatives |
| 09/18/2013 | CN103305596A Application and related pharmaceuticals of human ubiquitin-protein ligase 138 (RNF138) gene |
| 09/18/2013 | CN103305567A Bacillus calmette-guerin compound polysaccharide, and preparation method and use thereof |
| 09/18/2013 | CN103305549A Genetic vector system of nanoparticle with multiple oxidation-reduction stimulus response as well as preparation method and application of genetic vector system |
| 09/18/2013 | CN103305548A Method for expressing exogenous and endogenous genes by mouse intestinal DC cell mediated by oral gene engineering fermenting yeast and application |
| 09/18/2013 | CN103305535A Gene sequence of pig histone deacetylase 6 and application thereof |
| 09/18/2013 | CN103305523A Trichina Tsp-05904 recombinant protein antigen and preparation method thereof |
| 09/18/2013 | CN103305521A Sequence of aptamer of gastric cancer cell, and application thereof |
| 09/18/2013 | CN103305518A shRNA of human CD14 gene and application thereof |
| 09/18/2013 | CN103305515A Family with sequence similarity 84, member B (FAM84B) antisense nucleotide and application thereof |
| 09/18/2013 | CN103304804A Polyethylene glycol-polyamide-amine-polyamino acid linear-dendritic block polymer and preparation method thereof |
| 09/18/2013 | CN103304802A Acid-sensing amphipathic segmented copolymer as well as preparation method and application thereof |
| 09/18/2013 | CN103304680A Beta-glucan, and extraction method and application thereof |
| 09/18/2013 | CN103304669A Humanization tumor immune cell cytokines TNTIL2 as well as preparation method and application thereof |
| 09/18/2013 | CN103304668A Ultra-VEGF-trap immune fusion protein, its preparation method and application |
| 09/18/2013 | CN103304656A PaaspinosaDavid antibacterial peptide and application thereof |
| 09/18/2013 | CN103304638A PD-L1 affinity peptide with anti-tumour activity and application for same |
| 09/18/2013 | CN103304635A Application of cyclopeptide compound for preventing tumors and preparation method of compound |
| 09/18/2013 | CN103304633A Tubulin polymerizing agent polypeptides 1 and application thereof |
| 09/18/2013 | CN103304632A Tubulin polymerizing agent polypeptides 2 and application thereof |
| 09/18/2013 | CN103304631A Nonapeptide with anti-tumour activity |
| 09/18/2013 | CN103304622A Novel sea asparagus triterpenoid saponin reducing compound as well as preparation method and application thereof |
| 09/18/2013 | CN103304614A Novel compound capable of inhibiting tumor cell activity and preparation method as well as application thereof |
| 09/18/2013 | CN103304593A Dibutyl tin 4-dimethylaminobenzoate with trapezoid structure, as well as preparation method and application thereof |
| 09/18/2013 | CN103304592A Dibutyl tin 4-methylbenzoate with trapezoid structure, as well as preparation method and application thereof |
| 09/18/2013 | CN103304591A Dibutyltin 4-amino-3-methyl benzoate with tin-oxygen heterocyclic structure, and preparation method and application thereof |
| 09/18/2013 | CN103304584A 2-hydrazone-thiazolo[4,5-b]quinoxaline compounds, and preparation method and purpose thereof |
| 09/18/2013 | CN103304579A ortho-positioned bridged azacrown ether modified phthalocyanin and preparation method and application thereof |
| 09/18/2013 | CN103304575A Neogambogic acid derivative, preparation method thereof and pharmaceutical application |
| 09/18/2013 | CN103304574A Anticancer 4'-nor-anthricin and preparation method thereof |
| 09/18/2013 | CN103304573A Application of Lycorine compound in preparation of anti-tumor drugs |
| 09/18/2013 | CN103304572A 3-cyanoquinoline compound as well as pharmaceutical composition and application thereof |
| 09/18/2013 | CN103304571A Spiro compound as well as preparation method, intermediate, pharmaceutical composition and application thereof |
| 09/18/2013 | CN103304569A Erlotinib-phthalocyanine conjugate and preparation method thereof |